These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2835739)

  • 1. Amplification of the int-2 gene in primary human breast tumors.
    Lidereau R; Callahan R; Dickson C; Peters G; Escot C; Ali IU
    Oncogene Res; 1988 Feb; 2(3):285-91. PubMed ID: 2835739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of int-2 mRNA in human tumors amplified at the int-2 locus.
    Liscia DS; Merlo GR; Garrett C; French D; Mariani-Costantini R; Callahan R
    Oncogene; 1989 Oct; 4(10):1219-24. PubMed ID: 2677918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the int-1, int-2, c-myc, and neu oncogenes in human breast carcinomas.
    Meyers SL; O'Brien MT; Smith T; Dudley JP
    Cancer Res; 1990 Sep; 50(18):5911-8. PubMed ID: 1975511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal variations among multiple primary mammary tumors and within a tumor of individual mice: insertion mutations of int oncogenes.
    Sarkar NH
    Virology; 1995 Oct; 212(2):490-9. PubMed ID: 7571419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas.
    Theodorou V; Boer M; Weigelt B; Jonkers J; van der Valk M; Hilkens J
    Oncogene; 2004 Aug; 23(36):6047-55. PubMed ID: 15208658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA; Kittrell FS; Medina D; Butel JS
    Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proto-oncogene amplification and human breast tumor phenotype.
    Adnane J; Gaudray P; Simon MP; Simony-Lafontaine J; Jeanteur P; Theillet C
    Oncogene; 1989 Nov; 4(11):1389-95. PubMed ID: 2554239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL-1 participates in the 11q13 amplification found in breast cancer.
    Theillet C; Adnane J; Szepetowski P; Simon MP; Jeanteur P; Birnbaum D; Gaudray P
    Oncogene; 1990 Jan; 5(1):147-9. PubMed ID: 2181375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence of amplification of the C-erb B2/Her-2/neu gene in human breast cancer].
    Sellami M; Gamoudi M; Krichen K; Kharrat A; Ben Romdhane K; Maalej M
    Arch Inst Pasteur Tunis; 1991; 68(1-2):33-41. PubMed ID: 1687309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WNT and FGF gene clusters (review).
    Katoh M
    Int J Oncol; 2002 Dec; 21(6):1269-73. PubMed ID: 12429977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1.
    Tsuda H; Hirohashi S; Shimosato Y; Hirota T; Tsugane S; Yamamoto H; Miyajima N; Toyoshima K; Yamamoto T; Yokota J
    Cancer Res; 1989 Jun; 49(11):3104-8. PubMed ID: 2566377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: a role for hematopoietic growth factor release by tumor cells?
    Tang RP; Kacinski B; Validire P; Beuvon F; Sastre X; Benoit P; dela Rochefordière A; Mosseri V; Pouillart P; Scholl S
    J Cell Biochem; 1990 Nov; 44(3):189-98. PubMed ID: 1980125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of both Wnt-1 and Fgf-3 by insertion of mouse mammary tumor virus downstream in the reverse orientation: a reappraisal of the enhancer insertion model.
    Clausse N; Baines D; Moore R; Brookes S; Dickson C; Peters G
    Virology; 1993 May; 194(1):157-65. PubMed ID: 8386870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification and proviral activation of several Wnt genes during progression and clonal variation of mouse mammary tumors.
    Roelink H; Wagenaar E; Nusse R
    Oncogene; 1992 Mar; 7(3):487-92. PubMed ID: 1549363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel human Wnt gene, WNT10B, maps to 12q13 and is expressed in human breast carcinomas.
    Bui TD; Rankin J; Smith K; Huguet EL; Ruben S; Strachan T; Harris AL; Lindsay S
    Oncogene; 1997 Mar; 14(10):1249-53. PubMed ID: 9121776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogene amplification in breast cancer.
    Donovan-Peluso M; Contento AM; Tobon H; Ripepi B; Locker J
    Am J Pathol; 1991 Apr; 138(4):835-45. PubMed ID: 1849359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer.
    Hui R; Campbell DH; Lee CS; McCaul K; Horsfall DJ; Musgrove EA; Daly RJ; Seshadri R; Sutherland RL
    Oncogene; 1997 Sep; 15(13):1617-23. PubMed ID: 9380415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. int-2 and c-erbB-2 gene amplification detected in 70 frozen human breast carcinomas by quantitative polymerase chain reaction.
    An HX; Niederacher D; Dominik SI; Kuschel B; Yan H; Dall P; Schnürch HG; Bender HG; Beckmann MW
    Anticancer Res; 1997; 17(4B):3133-6. PubMed ID: 9329619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proto-oncogene abnormalities in human breast cancer: c-ERBB-2 amplification does not correlate with recurrence of disease.
    Zhou DJ; Ahuja H; Cline MJ
    Oncogene; 1989 Jan; 4(1):105-8. PubMed ID: 2915899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.
    Champème MH; Bièche I; Hacène K; Lidereau R
    Mod Pathol; 1994 Dec; 7(9):900-5. PubMed ID: 7892157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.